NAD

Eufy Says It Has Permanently Discontinued Claims for Robotic Vacuum Challenged by iRobot

Eufy, the maker of the RoboVac 11 Model T2101 robotic vacuum cleaner, has said it will discontinue all advertising claims challenged by iRobot Corporation before the NAD. iRobot challenged claims made by Eufy at its website and at Amazon.

Read More

NAD Finds Church & Dwight Can Support Certain Claims for ‘Slide’ Cat Litter; Recommends Company Modify, Discontinue Demonstration

NAD has determined that Church & Dwight Co., Inc., provided a reasonable basis for stand-alone performance claims made in product packaging, website, and broadcast advertising for the company’s Arm & Hammer Slide Cat Litter. NAD recommended the advertiser modify or discontinue the comparative product demonstration featured in the television and website advertising.

Read More

Beech-Nut Says It Has Permanently Discontinued Claims Challenged by Nestle, Maker of Gerber Products

The Beech-Nut Nutrition Company has said it will discontinue all advertising claims challenged by Nestle Nutrition U.S. before the NAD. Nestle, maker of Gerber infant foods, challenged claims made in advertising for Beech-Nut infant cereal products.

Read More

NAD Refers Claims Made by Synergy to FTC After Pharma Company Declines to Participate; Claims Challenged by Allergan

NAD has referred advertising claims made Synergy Pharmaceuticals, Inc., to the Federal Trade Commission after the advertiser declined to participate in a proceeding before NAD.

Read More

NAD Recommends Too Faced Cosmetics Discontinue ‘1,944% More Volume’ Claim for Better Than Sex Mascara, Advertiser to Appeal

NAD has recommended that Too Faced Cosmetics, LLC, discontinue the “1,944% more volume” claim – and before and after photographs – made on product packaging and online videos for the company’s Better Than Sex original and waterproof mascara. The company said it will appeal NAD’s decision.

Read More

‘Opiate Freedom Center’ Fails to Respond to NAD Inquiry, Ad Claims for ‘Detox,’ ‘Withdrawl’ Referred to FTC

NAD has referred advertising claims made by the “Opiate Freedom Center,” which markets “Opiate Freedom Center Dietary Supplement Systems,” to the FTC after the company failed to respond to an inquiry from NAD.

Read More